Overview

Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate Cancer

Status:
Terminated
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of short-term intake of daily Dutasteride in patients with prostate cancer.
Phase:
Phase 2
Details
Lead Sponsor:
University of Colorado, Denver
Collaborator:
GlaxoSmithKline
Treatments:
Dutasteride